Back to Nuveen, LLC Nuveen, LLC

INBXINBX

6 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in INHIBRX BIOSCIENCES INC

Yes. Nuveen holds 18,658 shares of INBX (Inhibrx Biosciences), worth $1.8M, as of its Q2 2026 13F filing. It increased the position by 1,481 shares (+8.6%) from Q1 2026. Nuveen has held INBX in every 13F on record since Q1 2025, 6 quarterly filings.

Current Value

$1.8M

Current Shares

18,658

Total Value Change

+$1.4M

Total Shares Change

-6,363

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
18,658
+8.6%
$1.8M0.0%$94.75
28
2026-Q1
Increased
17,177
+0.5%
$1.2M0.0%$74.33
25
2025-Q4
Decreased
17,090
-2.8%
$1.4M0.0%$77.98
0
2025-Q3
Decreased
17,584
-17.1%
$592,2290.0%$32.31
0
2025-Q2
Decreased
21,214
-15.2%
$302,7240.0%$14.43
0
2025-Q1
First report
25,021
—
$350,0440.0%$14.12
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used